EA202191159A1 - Лечение и профилактика преждевременной эякуляции (pe) - Google Patents

Лечение и профилактика преждевременной эякуляции (pe)

Info

Publication number
EA202191159A1
EA202191159A1 EA202191159A EA202191159A EA202191159A1 EA 202191159 A1 EA202191159 A1 EA 202191159A1 EA 202191159 A EA202191159 A EA 202191159A EA 202191159 A EA202191159 A EA 202191159A EA 202191159 A1 EA202191159 A1 EA 202191159A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
premature ejaculation
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
EA202191159A
Other languages
English (en)
Inventor
Даниэль Драй
Original Assignee
Серояк Пмэ Хандельс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Серояк Пмэ Хандельс Гмбх filed Critical Серояк Пмэ Хандельс Гмбх
Publication of EA202191159A1 publication Critical patent/EA202191159A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Saccharide Compounds (AREA)

Abstract

Раскрыта фармацевтическая композиция, содержащая кломипрамин или его фармацевтически приемлемую солевую форму и йохимбин или его фармацевтически приемлемую солевую форму, для применения в лечении и профилактике РЕ.
EA202191159A 2018-10-30 2019-10-30 Лечение и профилактика преждевременной эякуляции (pe) EA202191159A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18203410.8A EP3646871A1 (en) 2018-10-30 2018-10-30 Treatment and prevention of premature ejaculation (pe)
PCT/EP2019/079584 WO2020089261A1 (en) 2018-10-30 2019-10-30 Treatment and prevention of premature ejaculation (pe)

Publications (1)

Publication Number Publication Date
EA202191159A1 true EA202191159A1 (ru) 2021-07-21

Family

ID=64048779

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191159A EA202191159A1 (ru) 2018-10-30 2019-10-30 Лечение и профилактика преждевременной эякуляции (pe)

Country Status (16)

Country Link
US (1) US20210401852A1 (ru)
EP (2) EP3646871A1 (ru)
JP (1) JP2022506803A (ru)
KR (1) KR20210094551A (ru)
CN (1) CN113194950A (ru)
AU (1) AU2019370921A1 (ru)
BR (1) BR112021007839A2 (ru)
CA (1) CA3117345A1 (ru)
CL (1) CL2021001090A1 (ru)
EA (1) EA202191159A1 (ru)
ES (1) ES2925859T3 (ru)
IL (1) IL282686A (ru)
MA (1) MA54067A (ru)
MX (1) MX2021004997A (ru)
WO (1) WO2020089261A1 (ru)
ZA (1) ZA202102653B (ru)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
CN1241435A (zh) * 1999-06-01 2000-01-19 李光荣 能使***增粗长长并使其它性器官得到保健的外用药配方
GB0028245D0 (en) * 2000-11-20 2001-01-03 Pfizer Ltd New therapeutic use
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
GB0202282D0 (en) * 2002-01-31 2002-03-20 Pfizer Ltd Treatment of male sexual dysfunction
WO2005025550A1 (en) * 2003-09-15 2005-03-24 Vectura Limited Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
WO2007000764A2 (en) 2005-06-27 2007-01-04 Daniel Drai Compositions and methods for enhancement of sexual function
BR112013033475A2 (pt) * 2011-06-28 2017-12-19 Ctc Bio Inc composição farmacêutica para tratamento, prevenção ou melhora da ejaculação precoce e método para tratamento, prevenção ou melhora da ejaculação precoce
CN103948742B (zh) * 2014-05-12 2017-04-26 四川圣湖生物科技有限公司 一种改善雄性动物性功能障碍的药物组合物

Also Published As

Publication number Publication date
EP3646871A1 (en) 2020-05-06
AU2019370921A1 (en) 2021-05-20
US20210401852A1 (en) 2021-12-30
WO2020089261A1 (en) 2020-05-07
BR112021007839A2 (pt) 2021-08-03
MX2021004997A (es) 2021-08-24
CA3117345A1 (en) 2020-05-07
IL282686A (en) 2021-06-30
CN113194950A (zh) 2021-07-30
EP3873470B1 (en) 2022-05-18
ZA202102653B (en) 2022-07-27
KR20210094551A (ko) 2021-07-29
CL2021001090A1 (es) 2021-10-29
MA54067A (fr) 2022-01-26
ES2925859T3 (es) 2022-10-20
EP3873470A1 (en) 2021-09-08
JP2022506803A (ja) 2022-01-17

Similar Documents

Publication Publication Date Title
PH12019500579A1 (en) Pharmaceutical composition
CL2020003257A1 (es) Compuestos antagonistas de pcsk9.
PH12017501421A1 (en) Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n`-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
MX2022015272A (es) Inhibidores de la proteina kras g12c y usos de estos.
EA202092490A1 (ru) Модуляторы метилмодифицирующих ферментов, композиции и их применения
EA201890654A1 (ru) Терапевтические композиции для лечения вируса иммунодефицита человека
TR201901312T4 (tr) Mcl-1 proteinini inhibe eden tetrahidronaftalen türevleri.
PH12016502355A1 (en) Pharmaceutical composition
MX2021001807A (es) Combinacion de un inhibidor de histona desacetilasa y un inhibidor de proteina cinasa y uso farmaceutico de la misma.
EA202191239A1 (ru) Соединения и их применение для лечения дефицита 1-антитрипсина
MX2021002321A (es) Nuevos metodos.
PH12016502352A1 (en) Pharmaceutical composition
MX2019015212A (es) Compuestos para el tratamiento del sarcoma.
MX2021006156A (es) Compuestos utiles en la terapia para el vih.
PH12021550713A1 (en) Medicament for the treatment of chronic cough
MX2021002322A (es) Nuevos metodos.
MX2021001612A (es) Compuestos utiles en terapia del vih.
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
MX2021005944A (es) Inhibidores de rip1.
EA202190532A1 (ru) Ингибиторы аргиназы и способы их применения
EA201890896A1 (ru) Твердый препарат для перорального применения, содержащий аморфный солифенацин, и способ его получения
EA202191159A1 (ru) Лечение и профилактика преждевременной эякуляции (pe)
ZA202006986B (en) Dantrolene formulations and methods of their use
EA201890929A1 (ru) Низкие дозировки композиций дипиридамола для перорального приема и их использование
EA202191014A1 (ru) Производные 4-пиразин-2-илметил-морфолина и их применение в качестве лекарственного средства